Carrick Therapeutics
UKEntry
2021
Hold
5yr
Status
Active
Who owns Carrick Therapeutics?
Carrick Therapeutics is a British Biotech company, currently owned by Rosetta Capital since 2021 and Cambridge Innovation Capital.
Hand-verified · updated 2026-06-21
Open JSON · CC-BY
Most recent investor
Rosetta CapitalRosetta Capital V · 2021 · Secondaries
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2016 · present
Rosetta CapitalActive
2021 · present(5yr) · Rosetta Capital V · 2021 · Secondaries
More from Rosetta Capital V
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Carrick Therapeutics?
Carrick Therapeutics is currently owned by Rosetta Capital and Cambridge Innovation Capital, through Rosetta Capital V, since 2021.
When did Rosetta Capital and 1 other acquire Carrick Therapeutics?
Rosetta Capital and 1 other acquired Carrick Therapeutics in 2021.
Who has owned Carrick Therapeutics over time?
Carrick Therapeutics has been through 2 private-equity ownership periods: Cambridge Innovation Capital · via CIC Fund I · since 2016; Rosetta Capital · via Rosetta Capital V · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue